WallStSmart

Quipt Home Medical Corp (QIPT)vs111 Inc (YI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

111 Inc generates 5026% more annual revenue ($13.58B vs $264.97M). YI leads profitability with a -0.5% profit margin vs -4.0%. QIPT earns a higher WallStSmart Score of 40/100 (D).

QIPT

Hold

40

out of 100

Grade: D

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

YI

Avoid

31

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 3.45

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

QIPT2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
32.0%10/10

Revenue surging 32.0% year-over-year

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

YI2 strengths · Avg: 10.0/10
Debt/EquityHealth
-0.3010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.4510/10

Safe zone — low bankruptcy risk

Areas to Watch

QIPT4 concerns · Avg: 2.5/10
Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
1.5%3/10

Operating margin of 1.5%

Return on EquityProfitability
-9.3%2/10

ROE of -9.3% — below average capital efficiency

EPS GrowthGrowth
-97.7%2/10

Earnings declined 97.7%

YI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$58.07M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Revenue GrowthGrowth
-16.7%2/10

Revenue declined 16.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : QIPT

The strongest argument for QIPT centers on Revenue Growth, Price/Book. Revenue growth of 32.0% demonstrates continued momentum.

Bull Case : YI

The strongest argument for YI centers on Debt/Equity, Altman Z-Score.

Bear Case : QIPT

The primary concerns for QIPT are Market Cap, Operating Margin, Return on Equity.

Bear Case : YI

The primary concerns for YI are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

QIPT profiles as a hypergrowth stock while YI is a turnaround play — different risk/reward profiles.

YI carries more volatility with a beta of 0.64 — expect wider price swings.

QIPT is growing revenue faster at 32.0% — sustainability is the question.

YI generates stronger free cash flow (38M), providing more financial flexibility.

Bottom Line

QIPT scores higher overall (40/100 vs 31/100) and 32.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

111 Inc

HEALTHCARE · MEDICAL DISTRIBUTION · China

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?